A logo

A Agilent Technologies, Inc.

New York Stock Exchange · Medical - Diagnostics & Research · Healthcare

$175.34
-1.99 (-1.12%)

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry…

Market Cap: $49.44Bwww.agilent.com

Price

No data yet.

Social Signal Score

51
5d
50
3 mentions
—
30d
45
8 mentions
—
60d
50
13 mentions
—
90d
57
36 mentions
—
news: 22 · rss: 9 · marketaux: 4 · podcast: 1

Analyst Ratings

41 analysts
Buyconsensus
Strong Buy 1Buy 32Hold 7Sell 1Strong Sell 0
Avg price target$174.29-0.6%
Low $150Median $177.5High $195
Current Consensus

Revenue

$1.88B+69.04%
$1.07B$1.34B$1.61B$1.88B
Oct 2016Jul 2026

Analyst Estimates

FY2025
$5.57
$5.56–$5.58
12 analysts
FY2026
$6.20+11% YoY
$6.19–$6.42
13 analysts
FY2027
$6.70+8% YoY
$6.52–$6.98
13 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Padraig McDonnell
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
18,200
Beta
1.24
Country
US
Piotroski score
6 / 9 (Middling)
Altman Z-score
5.86
www.agilent.com